Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study: Evaluation of the Effectiveness and Safety of the Ulthera® System for Treatment of Erythematotelangiectatic Rosacea

NCT01756027 is registered in ClinicalTrials.gov with Ulthera, Inc as lead sponsor.

NCT NCT01756027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01756027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study: Evaluation of the Effectiveness and Safety of the Ulthera® System for Treatment of Erythematotelangiectatic Rosacea
Lead sponsor
Ulthera, Inc
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2012
Completion date
October 31, 2013
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erythematotelangiectatic rosacea